Tezetide is a new drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2DM). The drug has also demonstrated efficacy in weight loss, leading to its off-label use as an obesity treatment. Tizepatide is a dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin polypeptide (GIP) receptors. The drug can significantly improve blood sugar control and weight loss in patients with T2DM, similar to GLP-1 drugs such as semaglutide.

Thymosin Beta 4 (TB-500) is a muscle recovery drug. It is found in the body and is commonly found in skeletal muscles and all muscles of the body. Many bodybuilders inject TB-500 into their bodies to speed up the healing process of naturally occurring TB-500. It plays a vital role in building new blood vessels, new small muscle tissue fibers, cell migration, and blood cell reproduction. The main purpose is to increase the production of actin in the body, which is associated with muscle repair.

CAS No.: 1415456-99-3
Formula: C50h69n15o9
EINECS: 137-1655-0673
Classification: Biochemical Reagents
Grade: AR
Specific Usage: For Biological Purpose, For Tissue Medium Purpose, For Microbiological, For Microscopic Purpose, For Electron Microscopy, For Lens Blooming, Technical Grade, Pratical Use, Pro Analysis, Super Special Grade, For Synthesis, For Scintillation, For Electrophoresis Use, For Refractive Index